Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

The clinical use and immunologic impact of thrombin in surgery.

Lawson JH.

Semin Thromb Hemost. 2006 Apr;32 Suppl 1:98-110. Review.

PMID:
16673271
2.

A review of three stand-alone topical thrombins for surgical hemostasis.

Cheng CM, Meyer-Massetti C, Kayser SR.

Clin Ther. 2009 Jan;31(1):32-41. doi: 10.1016/j.clinthera.2009.01.005. Review.

PMID:
19243705
3.

Bovine thrombin: history, use, and risk in the surgical patient.

Diesen DL, Lawson JH.

Vascular. 2008 Mar-Apr;16 Suppl 1:S29-36. Review. Erratum in: Vascular. 2009 May-Jun;17(3):181.

PMID:
18544303
4.

A phase 3b, open-label, single-group immunogenicity and safety study of topical recombinant thrombin in surgical hemostasis.

Singla NK, Ballard JL, Moneta G, Randleman CD Jr, Renkens KL, Alexander WA.

J Am Coll Surg. 2009 Jul;209(1):68-74. doi: 10.1016/j.jamcollsurg.2009.03.016. Epub 2009 May 28.

PMID:
19651065
5.

Phase 3, randomized, double-blind study of plasma-derived human thrombin versus bovine thrombin in achieving hemostasis in patients undergoing surgery.

Doria C, Fischer CP, Wood CG, Li PM, Marra S, Hart J.

Curr Med Res Opin. 2008 Mar;24(3):785-94. doi: 10.1185/030079908X273426. Epub 2008 Jan 31.

PMID:
18241525
6.

Recent developments in topical thrombins.

Kessler CM, Ortel TL.

Thromb Haemost. 2009 Jul;102(1):15-24. doi: 10.1160/TH09-01-0034. Review.

PMID:
19572062
7.

A comparison of recombinant thrombin to bovine thrombin as a hemostatic ancillary in patients undergoing peripheral arterial bypass and arteriovenous graft procedures.

Weaver FA, Lew W, Granke K, Yonehiro L, Delange B, Alexander WA; Study Investigators.

J Vasc Surg. 2008 Jun;47(6):1266-73. doi: 10.1016/j.jvs.2008.01.034. Epub 2008 Apr 28.

8.

A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins.

Ofosu FA, Crean S, Reynolds MW.

Clin Ther. 2009 Apr;31(4):679-91. doi: 10.1016/j.clinthera.2009.04.021. Review.

PMID:
19446142
9.

Recombinant human thrombin: in surgical hemostasis.

Croxtall JD, Scott LJ.

BioDrugs. 2009;23(5):333-8. doi: 10.2165/11202650-000000000-00000. Review.

PMID:
19754221
10.

Development of antibodies to topical bovine thrombin after abdominal hysterectomy. A case report.

Adams JD, Jones S, Brost BC.

J Reprod Med. 2001 Oct;46(10):909-12.

PMID:
11725736
11.

Antiphospholipid antibodies after surgical exposure to topical bovine thrombin.

Su Z, Izumi T, Thames EH, Lawson JH, Ortel TL.

J Lab Clin Med. 2002 Jun;139(6):349-56.

PMID:
12066133
12.

Comparison of recombinant human thrombin and plasma-derived human alpha-thrombin.

Bishop PD, Lewis KB, Schultz J, Walker KM.

Semin Thromb Hemost. 2006 Apr;32 Suppl 1:86-97. Review.

PMID:
16673270
13.

Immune-mediated coagulopathy: a case report.

Naoum JJ.

Pharmacotherapy. 2009 Jul;29(7 Pt 2):13S-7S. doi: 10.1592/phco.29.pt2.13S.

PMID:
19558280
14.

Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors.

Berruyer M, Amiral J, Ffrench P, Belleville J, Bastien O, Clerc J, Kassir A, Estanove S, Dechavanne M.

J Thorac Cardiovasc Surg. 1993 May;105(5):892-7.

PMID:
8487567
15.

Exposure of mice to topical bovine thrombin induces systemic autoimmunity.

Schoenecker JG, Johnson RK, Lesher AP, Day JD, Love SD, Hoffman MR, Ortel TL, Parker W, Lawson JH.

Am J Pathol. 2001 Nov;159(5):1957-69.

16.

A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis.

Chapman WC, Singla N, Genyk Y, McNeil JW, Renkens KL Jr, Reynolds TC, Murphy A, Weaver FA.

J Am Coll Surg. 2007 Aug;205(2):256-65. Epub 2007 Jun 27.

PMID:
17660072
17.

Development of antibodies to bovine and human factor V in two children after exposure to topical bovine thrombin.

Israels SJ, Israels ED.

Am J Pediatr Hematol Oncol. 1994 Aug;16(3):249-54.

PMID:
8037345
19.

Thrombin products: economic impact of immune-mediated coagulopathies and practical formulary considerations.

Voils SA.

Pharmacotherapy. 2009 Jul;29(7 Pt 2):18S-22S. doi: 10.1592/phco.29.pt2.18S.

PMID:
19558281
20.

Topical thrombins: benefits and risks.

Lomax C, Traub O.

Pharmacotherapy. 2009 Jul;29(7 Pt 2):8S-12S. doi: 10.1592/phco.29.pt2.8S.

PMID:
19558279
Items per page

Supplemental Content

Write to the Help Desk